Cai Changjing, Shen Hong, Liu Wenqiang, Ma Junli, Zhang Yan, Yin Ling, Li Jindong, Shen Liangfang, Zeng Shan
Department of Oncology Institute of Medical Sciences, Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Medicine (Baltimore). 2017 Nov;96(45):e8373. doi: 10.1097/MD.0000000000008373.
Thyroid metastasis from nasopharyngeal carcinoma is rare. Metastasis of nasopharyngeal carcinoma to the thyroid gland with subsequent metastatic abdominal lymph nodes hasn't been reported before. We want to share our experience about the treatment choice.
A 27-year-old man was diagnosed with nasopharyngeal nonkeratinizing carcinoma in August 2004. In March 2013 he underwent a thyroid carcinoma radical operation, and histological examination revealed metastasis to the thyroid gland from nasopharyngeal carcinoma. An 18F-FDG-PET/CT scan and biopsy showed metastatic abdominal lymph nodes of nasopharyngeal carcinoma in April 2015.
A 27-year-old man was diagnosed with metastasis of nasopharyngeal carcinoma to the thyroid gland with subsequent metastatic abdominal lymph nodes.
The patient was treated with concurrent chemotherapy and radiotherapy for nasopharyngeal carcinoma and metastasis to the thyroid gland. The metastases to the abdominal lymph nodes received chemotherapy.
After 6 cycles of chemotherapy with gemcitabine, cisplatin, and 5-fluorouracil for metastasis to the abdominal lymph nodes, the patient is currently asymptomatic with stable disease and improved quality of life.
The treatment choice for metastasis of nasopharyngeal carcinoma depends on the clinical disease extent, and surgery and/or chemo-radiation therapy must be drafted to the individual patient in order to improve the prognosis and quality of life.
鼻咽癌发生甲状腺转移较为罕见。鼻咽癌转移至甲状腺并继发腹部淋巴结转移此前未见报道。我们想分享一下关于治疗选择的经验。
一名27岁男性于2004年8月被诊断为鼻咽非角化癌。2013年3月他接受了甲状腺癌根治手术,组织学检查显示为鼻咽癌转移至甲状腺。2015年4月,18F-FDG-PET/CT扫描及活检显示存在鼻咽癌腹部转移淋巴结。
一名27岁男性被诊断为鼻咽癌转移至甲状腺并继发腹部转移淋巴结。
该患者接受了针对鼻咽癌及甲状腺转移灶的同步放化疗。腹部淋巴结转移灶接受了化疗。
使用吉西他滨、顺铂和5-氟尿嘧啶对腹部淋巴结转移灶进行6个周期化疗后,患者目前无症状,病情稳定,生活质量改善。
鼻咽癌转移的治疗选择取决于临床疾病范围,必须根据个体患者制定手术和/或放化疗方案,以改善预后和生活质量。